Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 3.41% is in line with its 1-year average of 3.37%, near the high end of its 1-year range (2.55%–3.74%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.34% above its 12-month average of 3.37%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 3.41%.
RETURN ON EQUITY (ROE)
3.41%
RETURN ON EQUITY (ROE) AVG TTM
3.37%
RETURN ON EQUITY (ROE) AVG 3Y
N/A
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+1.34%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · FINANCIAL SERVICES
8.76%
median of 677 covered companies
CURRENT VS SECTOR MEDIAN
-61.02%
vs the sector median at left
Oaktree Acquisition Corp. II
Market Cap
$264.51M
Return on Equity (ROE)
3.41%
TTM Avg
3.37%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.47M
Return on Equity (ROE)
3.49%
TTM Avg
2.30%
3Y Avg
2.30%
5Y Avg
2.30%
Market Cap
$263.53M
Return on Equity (ROE)
183.78%
TTM Avg
142.95%
3Y Avg
142.95%
5Y Avg
142.95%
Market Cap
$263.18M
Return on Equity (ROE)
4.42%
TTM Avg
99.43%
3Y Avg
99.43%
5Y Avg
99.43%
Market Cap
$266.29M
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.99M
Return on Equity (ROE)
3.70%
TTM Avg
1.79%
3Y Avg
104.71%
5Y Avg
104.71%
Market Cap
$267.54M
Return on Equity (ROE)
14.45%
TTM Avg
12.94%
3Y Avg
10.71%
5Y Avg
11.49%
Market Cap
$261.73M
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.45M
Return on Equity (ROE)
1.17%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oaktree Acquisition Corp. II (OACC) | $264.51M | 3.41% | 3.37% | N/A | N/A |
| ProCap Acquisition Corp (PCAP)vs › | $264.47M | 3.49% | 2.30% | 2.30% | 2.30% |
| Soren Acquisition Corp. (SORN)vs › | $263.53M | 183.78% | 142.95% | 142.95% | 142.95% |
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)vs › | $263.18M | 4.42% | 99.43% | 99.43% | 99.43% |
| Thunder Bridge Capital Partners V L (TBCVU)vs › | $266.29M | N/A | N/A | N/A | N/A |
| Translational Development Acquisition Corp. (TDAC)vs › | $266.99M | 3.70% | 1.79% | 104.71% | 104.71% |
| Hawthorn Bancshares, Inc. (HWBK)vs › | $267.54M | 14.45% | 12.94% | 10.71% | 11.49% |
| AMR Resources Acquisition Corp Class A Ordinary Shares (AMAC)vs › | $261.73M | N/A | N/A | N/A | N/A |
| GigCapital8 Corp. (GIW)vs › | $261.45M | 1.17% | 0.00% | 0.00% | 0.00% |
| Mountain Lake Acquisition Corp. II Class A Ordinary Shares (MLAA)vs › | $261.39M | N/A | N/A | N/A | N/A |
ROE
3.4%
ROA
3.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 3.41% |
| 2026-03-31 | 3.58% |
| 2025-12-31 | 3.74% |
| 2025-09-30 | 3.56% |
| 2025-06-30 | 2.55% |
